Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FKE12
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,088
Award facts
- Contract value 100% obligated
- $50,087.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $50,087.79 for Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials. The contract carries a firm fixed price structure with an ultimate completion date of September 30, 2025, and was awarded on September 29, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026 that enables comprehensive pharmaceutical support to military healthcare systems globally.
AmerisourceBergen's federal contracting activity demonstrates the company's critical role in supplying pharmaceuticals and medical supplies to Department of Defense and veteran healthcare systems. The delivery order for Ozempic, a diabetes medication, exemplifies the company's portfolio of therapeutic products spanning endocrinology, neurology, pain management, and specialty pharmaceuticals. The DLA's reliance on AmerisourceBergen through the Pharmaceutical Prime Vendor program reflects the company's established capability to meet federal procurement requirements and support military medical operations across multiple service branches and healthcare entities, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FKE12?
SPE2DB25FKE12 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FKE12 worth?
The government has obligated $50,088 on SPE2DB25FKE12.
Is contract SPE2DB25FKE12 an order under another contract?
Yes. SPE2DB25FKE12 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKE12 competed?
The extent of competition for SPE2DB25FKE12 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award